国际麻醉学与复苏杂志   2022, Issue (5): 8-8
    
阿片受体介导心肌缺血/再灌注损伤保护作用的研究进展
陈振星, 张野1()
1.安徽医科大学第二附属医院
Research progress on opioid receptor‑mediated protection against myocardial ischemia/reperfusion injury
 全文:
摘要:

心肌缺血/再灌注损伤(myocardial ischemia/reperfusion injury, MI/RI)是心肌梗死后冠状动脉血管再通常见的并发症,严重影响患者的康复,甚至威胁患者生命安全。而阿片类药物不仅具有镇痛作用,还具有心脏保护作用,此作用依赖于阿片受体(opioid receptor, OR)的激活。κ‑OR、δ‑OR的激活直接参与心肌保护,而μ‑OR的作用及其作用机制尚存在争议。此外,不同激动剂对3种OR亚型的不同亲和力使得“OR介导的心脏保护”这一结论具有争议。文章就内源性阿片肽类物质及外源性阿片类药物(如吗啡、芬太尼、瑞芬太尼、布托啡诺、美沙酮)对MI/RI的保护作用进行综述,讨论不同OR介导MI/RI保护作用的机制及其与G蛋白耦联受体(G protein‑coupled receptor, GPCR)家族其他成员的串扰,以及可能的上下游信号通路,以便为未来开发改善心肌、挽救心肌的药物提供参考。

关键词: 缺血/再灌注损伤; 心肌; 阿片受体; 心肌保护
Abstract:

Myocardial ischemia/reperfusion injury (MI/RI) is a common complication of coronary artery recanalization after myocardial infarction, which seriously affects the recovery of patients and even threatens their life. Opioids can not only provide analgesia, but also protect the heart, which depends on the activation of opioid receptor (OR). The activation of κ‑OR and δ‑OR is directly involved in myocardial protection, while the role and mechanism of μ‑OR remain controversial. In addition, the affinity of different agonists to three OR subtypes makes the conclusion "OR mediated cardiac protection" controversial. This paper reviews the protective effects of endogenous opioid peptides and exogenous opioids such as morphine, fentanyl, remifentanil, butorphanol and methadone on MI/RI. At the same time, we will further discuss the mechanisms of different opioid receptors mediated cardioprotection, their crosstalk with other members of the G protein‑coupled receptor (GPCR) family, and possible upstream and downstream signaling pathways to provide enlightenment for development of drugs in the future.

Key words: Ischemia reperfusion injury; Myocardium; Opioid receptor; Myocardial protection